Barclays Lowers Humana (HUM) Price Target amid Questions on Margin Expansion Outlook

Humana Inc. (NYSE:HUM) is included among the 14 Best GARP Stocks to Buy According to Analysts. Barclays Lowers Humana (HUM) Price Target amid Questions on Margin Expansion Outlook On February 25, Barclays lowered its price recommendation on Humana Inc. (NYSE:HUM) to $176 from $245. The firm reiterated an Equal Weight rating on the shares. It said it is “incrementally cautious” about the company’s expectation that Individual Medicare Advantage margins will double. A February 14 Bloomberg report said Huma ...